Skip to content
Stop using now Drug recall · FDA · Published December 3, 2014

Hospira Recalls Fentanyl Citrate Vials Due to Sterility Risk

Hospira Inc. recalls specific lots of Fentanyl Citrate Injection vials due to improperly crimped fliptops and lack of sterility assurance.

🇺🇸 FDA recall #D-0294-2015DrugHospira ›
Take action

Contact the company

Recalling firmHospira Inc.375 N Field Dr · Lake Forest, IL 60045-2513
✎ GovInfoNow plain-language explainer

Hospira Inc. is recalling 62,650 vials of Fentanyl Citrate Injection, USP (2500 mcg/50 mL) because the fliptop vials were improperly crimped. This defect creates a lack of assurance that the drug remains sterile during use. The recall affects units distributed nationwide with expiration date May 1, 2016. Read more at govinfonow.com/recall/45140-hospira-inc-recalls-fentanyl-citrate-injection-usp-2500-mcg-fentanyl.

Source Summary by GovInfoNow · govinfonow.com/recall/45140-hospira-inc-recalls-fentanyl-citrate-injection-usp-2500-mcg-fentanyl · Updated October 12, 2026 · FDA enforcement record: FDA #D-0294-2015

Cite this page

“Hospira Recalls Fentanyl Citrate Vials Due to Sterility Risk.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45140-hospira-inc-recalls-fentanyl-citrate-injection-usp-2500-mcg-fentanyl. Based on FDA recall #D-0294-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0294-2015%22&limit=1).

The FDA announced on December 3, 2014, that Hospira Inc. is recalling Fentanyl Citrate Injection due to a lack of assurance of sterility caused by improperly crimped fliptop vials. The agency classified the recall as Class II.

How to tell if you have it

  • Brand: Hospira
  • Product: Fentanyl Citrate Injection, USP, 2500 mcg Fentanyl/50 mL, 50 mL Single-dose Flip top Vial (C-II), Rx only
  • NDC: 0409-9094-61
  • Lot code: 41-099-DK
  • Expiration date: 01MAY2016
  • Quantity: 62,650 vials

The hazard

The recall addresses a lack of assurance of sterility resulting from improperly crimped fliptop vials. The FDA classified the recall as Class II.

Context

GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls of similar products include Huons Co Lidocaine HCl Injection Recall (April 2, 2026) and Wells Pharma Fentanyl Citrate Injectable Solution Recall (April 1, 2026).

How to tell if you have this one

Check for Fentanyl Citrate Injection, USP, 2500 mcg Fentanyl/50 mL in 50 mL Single-dose Flip top Vials manufactured by Hospira Inc. Look for NDC 0409-9094-61 and Lot number 41-099-DK with an expiration date of 01MAY2016.

  • Brand
    Hospira
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Identify Affected Vials

    Verify if your inventory includes NDC 0409-9094-61, Lot 41-099-DK, expiring 01MAY2016.

  2. Cease Use Immediately

    Do not use the recalled vials due to the risk of non-sterile contents.

  3. Contact Manufacturer

    Reach out to Hospira Inc. for further instructions on handling or returning the product.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 10 months after the firm started it.

1. Firm started the recall: Dec 3, 201412. FDA classified it Class II: Dec 10, 201423. Published in FDA’s Enforcement Report: Dec 17, 201434. FDA terminated the recall: Oct 2, 2015420142015
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What is the NDC number for the affected product?

The National Drug Code (NDC) for the recalled item is 0409-9094-61.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0294-2015 (December 3, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0294-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA